Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid + xylitol is a topical nasal irrigation solution primarily used for postoperative care following endonasal surgeries, such as septoplasty, turbinate reduction, and endoscopic sinus surgery. The combination leverages the regenerative and anti-inflammatory properties of hyaluronic acid, which promotes mucosal healing and forms a protective barrier, alongside the anti-adhesive properties of xylitol, which inhibits bacterial biofilm formation and reduces nasal crusting. Marketed under brand names like Aluneb, it is typically administered via a mucosal atomization device (MAD) or nebulizer. Clinical studies have demonstrated its efficacy in reducing postoperative symptoms, including nasal obstruction and epistaxis, more effectively than standard saline solutions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid + xylitol.